AWAU
TMO icon

Alliance Wealth Advisors (Utah)’s Thermo Fisher Scientific TMO Stock Holding History

Alliance Wealth Advisors (Utah)’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$271K Sell
540
-227
-30% -$109K 0.05% 200
2026
Q1 		$377K Sell
767
-277
-27% -$150K 0.08% 168
2025
Q4 		$605K Sell
1,044
-228
-18% -$129K 0.13% 152
2025
Q3 		$617K Sell
1,272
-5,045
-80% -$2.35M 0.14% 156
2025
Q2 		$2.56M Sell
6,317
-390
-6% -$163K 0.62% 54
2025
Q1 		$3.34M Sell
6,707
-430
-6% -$233K 0.87% 38
2024
Q4 		$3.71M Sell
7,137
-271
-4% -$149K 0.96% 26
2024
Q3 		$4.58M Buy
7,408
+128
+2% +$75.8K 1.2% 16
2024
Q2 		$4.03M Buy
7,280
+191
+3% +$109K 1.18% 17
2024
Q1 		$4.12M Buy
7,089
+3,192
+82% +$1.79M 1.23% 16
2023
Q4 		$2.07M Buy
3,897
+40
+1% +$19.4K 0.69% 48
2023
Q3 		$1.95M Buy
3,857
+167
+5% +$89K 0.72% 45
2023
Q2 		$1.93M Buy
3,690
+171
+5% +$92.3K 0.71% 47
2023
Q1 		$2.03M Buy
3,519
+162
+5% +$91.3K 0.82% 39
2022
Q4 		$1.85M Buy
+3,357
New +$1.78M 0.83% 37

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Alliance Wealth Advisors (Utah)'s TMO Position: Q2 2026 in Review

Alliance Wealth Advisors (Utah) reduced its Thermo Fisher Scientific (TMO) stake by 30% in Q2 2026, selling an estimated $109K and leaving 540 shares worth $271K. The position accounts for 0.05% of the portfolio, ranked #200.

Alliance Wealth Advisors (Utah) first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.58M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Alliance Wealth Advisors (Utah) held 540 shares of Thermo Fisher Scientific worth $271K as of Q2 2026.
  • Alliance Wealth Advisors (Utah) sold 227 Thermo Fisher Scientific shares in Q2 2026, an estimated $109K.
  • Thermo Fisher Scientific made up 0.05% of Alliance Wealth Advisors (Utah)'s portfolio in Q2 2026, its #200 holding.
  • Alliance Wealth Advisors (Utah) first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • Alliance Wealth Advisors (Utah)'s Thermo Fisher Scientific position peaked at $4.58M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Alliance Wealth Advisors (Utah)'s 13F filing for Q2 2026, filed 23 Jul 2026.